Curriculum
- 11 Sections
- 147 Lessons
- 16 Hours
Expand all sectionsCollapse all sections
- Module 1: Introduction to Epidemiology in Clinical Practice14
- 1.1Module Outline
- 1.21. Overview of Epidemiology and Its Relevance to Patient Care
- 1.31.1 What is Epidemiology and Clinical Epidemiology?
- 1.41.2 The Purpose of Clinical Epidemiology
- 1.51.3 Basic Principles of Epidemiology
- 1.62. Role of Epidemiological Methods in Improving Clinical Outcomes
- 1.72.1 Use of Epidemiological Findings to Guide Treatment Protocols and Public Health Policies
- 1.82.2 Evidence-Based Clinical Guidelines Derived from Epidemiological Research
- 1.92.3 Sensitivity, Specificity and Predictive Value in Diagnostic Tests
- 1.102.4 Role in Improving the Accuracy and Reliability of Clinical Diagnostics
- 1.112.5 Real-World Example: How Epidemiological Research Influenced Clinical Practice
- 1.123. Differentiating between clinical epidemiology and population epidemiology
- 1.133.1 Differences between clinical and population epidemiology
- 1.143.2 Interconnection Between Clinical and Population Epidemiology- How Population Epidemiology Informs Clinical Practice
- Module 2: Screening and Early Detection of Disease18
- 2.1Module Outline
- 2.21. Principles and Criteria for Effective Screening Programs
- 2.31.1 Definition of Screening Programs
- 2.41.2 Requirements for Instituting a Medical Screening Programme (Modern Criteria) and Revisiting the Wilson and Jungner Criteria
- 2.51.3 Types of Screening
- 2.61.4 Cost Effectiveness and Allocation in Screening
- 2.71.5 Over Diagnosis, Lead Time Bias, and Length Bias
- 2.81.6 Ethical Considerations in Screening
- 2.92. Use of Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value in Evaluating Screening Tests
- 2.102.1 Biologic Variation of Human Population
- 2.112.2 Validity of Screening Tests
- 2.122.3 Measures of Validity in Screening Tests
- 2.132.4 Measures of Performance in Screening
- 2.142.5 Relationship Between Predictive Value and Disease Prevalence
- 2.152.6 Receiver Operating Characteristic (ROC) Curves and Area Under The Curve (AUC)
- 2.162.7 Trade-Offs Between Sensitivity and Specificity
- 2.172.8 Application of Bayes’ Theorem in Interpreting Screening Results
- 2.182.9 Case Studies of Successful Screening Initiatives
- Module 3: Application of Epidemiology in Clinical Practice13
- 3.1Module Outline
- 3.21. Application of Incidence & Prevalence in Clinical Settings
- 3.31.1 Introduction to Incidence & Prevalence in Public Health
- 3.41.2 Using Disease Data to Guide Screening & Prevention
- 3.52. The Role of Relative Risk, Odds Ratio, and Hazard Ratio for Clinical Decision-Making
- 3.62.1 Introduction to Risk Measures in Epidemiology
- 3.72.2 Understanding Relative Risk (Risk Ratio)
- 3.82.3 Understanding Odds Ratio (OR) – Concept & Interpretation
- 3.92.4 Understanding Hazard Ratio (HR) – Concept & Interpretation
- 3.103. Using Epidemiological Data to Assess Patient Prognosis & Treatment Options
- 3.113.1 Understanding Survival Analysis & Life Tables
- 3.123.2 How Survival Data Helps in Selecting the Best Treatment
- 3.133.3 How Bias Affects Survival Data & Clinical Decisions
- Module 4: Application of Study Designs in Patient Care13
- 4.1Module Outline
- 4.21. How Cohort, Case-Control, and Cross-Sectional Studies Inform Clinical Decisions
- 4.31.1. Features of Cohort Studies and Their Use in Risk-Factor Analysis
- 4.41.2. Case-Control Study Methodology – Selecting Controls and Analysing Odds
- 4.51.3. Cross-Sectional Studies for Prevalence Measurement and Healthcare Surveys
- 4.62. The Impact of Randomised Controlled Trials (RCTs) on Treatment Protocols
- 4.72.1. Designing and Conducting RCTs
- 4.82.2. Real-World Examples of RCTs Influencing Practice
- 4.92.3. Ethical Considerations in Conducting RCTs
- 4.103. Understanding Observational Studies and Their Relevance to Real-World Patient Care
- 4.113.1. Role of Observational Studies in Understanding Long-Term Outcomes
- 4.123.2. Common Biases and Their Mitigation
- 4.133.3. Examples of Observational Studies Leading to Policy Changes
- Module 5: Evidence-Based Medicine in Clinical Practice1
- Module 6: Surveillance Systems and Clinical Decision Making20
- 6.1Module Outline
- 6.21. Role of Disease Surveillance in Guiding Clinical Practice
- 6.31.1 Definition and Scope of Disease Surveillance
- 6.41.2 Importance of Early Detection and Response to Emerging Health Threats
- 6.51.3 Types of Surveillance
- 6.61.4 Integration of Surveillance Data in Clinical Workflow
- 6.71.5 Limitations and Challenges in Using Surveillance Data in Clinical Practice
- 6.82. Using Epidemiological Data from National & Global Health Surveillance Systems
- 6.92.1 Overview of Major Health Surveillance Systems
- 6.102.2 How Surveillance Data Informs Policies & Clinical Guidelines
- 6.112.3 Methods for Accessing & Interpreting Surveillance Reports
- 6.122.4 Role of Epidemiological Dashboards
- 6.132.5 Examples of Data-Driven Response
- 6.142.6 Global Challenges and Examples
- 6.153. Real-Time Application of Epidemiological Surveillance in Patient Care
- 6.163.1 Real-Time Disease Tracking Tools
- 6.173.2 Surveillance Informing Clinical Practice
- 6.183.3 Application of Predictive Analytics and Artificial Intelligence
- 6.193.4 Challenges of Using Real-Time Surveillance
- 6.203.5 Collaboration Between Public and Healthcare Systems for Rapid Response
- Module 7: Introduction to Epidemiology in Clinical Practice13
- 7.1Module Outline
- 7.21. Role of Epidemiology in Controlling Infectious Disease Outbreaks
- 7.31.1 Basics of Transmission Dynamics (Agent, Host, Environment)
- 7.41.2 Phases of Infectiousness: Incubation, Latent, Communicable, and Generation Time
- 7.51.3 Application in Outbreak Control (e.g., Cholera, Dengue, COVID-19)
- 7.62. Application of Epidemiological Models in Clinical Settings
- 7.72.1 R0: Impact on Outbreak Control and Clinical Workflows (e.g., Quarantine Duration)
- 7.82.2 Herd Immunity: Vaccine Coverage Thresholds (e.g., Measles, Polio)
- 7.92.3 Limitations of Models in Real-World Patient Care Settings
- 7.103. Case Management and Contact Tracing Strategies in Infectious Diseases
- 7.113.1 Isolation and Treatment Protocols for Infectious Diseases (e.g., TB, COVID-19)
- 7.123.2 Contact Tracing Principles: Incubation Periods, Communicability, and Prioritization
- 7.133.3 Challenges in High-Density Settings Like Hospitals and Slums
- Module 8: Epidemiology and Chronic Disease Management16
- 8.1Module Outline
- 8.21. Use of Epidemiological Data in Managing Chronic Conditions
- 8.31.1. Advanced Data Analytics in Chronic Disease Management
- 8.41.2 Geospatial Analysis for Chronic Disease Surveillance (Mapping disease hotspots to allocate healthcare resources)
- 8.51.3 Integration of Electronic Health Records (EHR) in Epidemiological Studies (Leveraging EHR data for real-time disease monitoring)
- 8.61.4 Assessing the impact of socioeconomic factors on disease prevalence
- 8.71.5 Policy and Legal Frameworks for Data Sharing in Chronic Disease Management
- 8.82. Long-term Follow-up and Surveillance in Chronic Disease Care
- 8.92.1 Strategies to Improve Patient Adherence and Engagement in Long-term Follow-up
- 8.102.2 Implementing telehealth and mobile health (mHealth) solutions in chronic diseases surveillance
- 8.112.3 Data Integration and Analysis for Long-term Surveillance
- 8.123. Impact of lifestyle interventions based on epidemiological research
- 8.133.1 Evidence based lifestyle modification programs
- 8.143.2 Epidemiological Studies Supporting the Effectiveness of Lifestyle Changes in Reducing Risk Factors
- 8.153.3 Long-term impacts of lifestyle interventions: Data from longitudinal studies showing benefits in managing chronic diseases
- 8.163.4 Insights from Epidemiological Research on Effective Behavioral Interventions
- Module 9: Health Outcomes and Patient-Centred Care1
- Module 10: Epidemiology in Public Health37
- 10.1Module Outline
- 10.21. Role of Epidemiology in Public Health Policy & Program Planning
- 10.31.1. Data Collection and Analysis for Policy Development
- 10.41.2. Role of Epidemiology in Setting Health Priorities
- 10.51.3. Evidence-Based Public Health Planning
- 10.61.4. Evaluating the Impact of Public Health Policies
- 10.71.5. Case Studies: Tobacco Control, Vaccination Policies
- 10.82. Epidemiology of Emerging & Re-emerging Diseases
- 10.92.1. Factors Driving the Emergence and Re-Emergence of Diseases
- 10.102.2. Global Health Surveillance Systems
- 10.112.3. Examples: Zika Virus, Ebola, Antimicrobial Resistance, COVID-19, SARS, MERS, HMPV
- 10.122.4. Role of One Health Approach
- 10.132.5. Strategies for Prevention and Control
- 10.143. Travel-Related Epidemiology for Infectious Diseases & Global Health Risks
- 10.153.1. Epidemiology and Travel-Related Infections (eg: Malaria, Dengue, COVID-19)
- 10.163.2. Vaccination Requirements for Travelers
- 10.173.3. Role of International Health Regulations (IHR)
- 10.183.4. Disease Mapping and Risk Assessment for Travelers
- 10.193.5. Public Health Advisories and Travel Bans
- 10.204. Monitoring NCD Trends & Interventions
- 10.214.1. Epidemiology of Key NCDs (Diabetes, Cardiovascular Diseases, Cancers, etc.)
- 10.224.2. Surveillance Systems for NCDs
- 10.234.3. Evaluation of NCD Interventions (eg: Lifestyle Modifications, Medication Adherence)
- 10.244.4. Impact of Social Determinants on NCD Trends
- 10.254.5. Global Initiatives to Combat NCDs (WHO Global NCD Action Plan)
- 10.265. Environmental & Occupational Health Risks
- 10.275.1. Principles of Environmental Epidemiology
- 10.285.2. Epidemiologic Methods in Occupational Health
- 10.295.3. Health Impacts of Air and Water Pollution
- 10.305.4. Occupational Exposure to Chemicals and Carcinogens
- 10.315.5. Emerging Issues: Climate Change, Urbanization
- 10.326. Public Health Interventions & Emergency Responses
- 10.336.1. Epidemiologic Basis for Vaccination Programs
- 10.346.2. Tobacco Control: Epidemiology and Policy
- 10.356.3. Managing Infectious Disease Outbreaks
- 10.366.4. Risk Communication During Public Health Emergencies
- 10.376.5. Role of Epidemiology in Disaster Preparedness and Response
- Module 11: Ethical Considerations in Clinical Epidemiology1
